High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci189207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Benjamin E Warner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Virology Program, UPMC Hillman Cancer Center. Hauptthemen laut MEDLINE: Immunoglobulin G, Nasopharyngeal Neoplasms, Herpesvirus 4, Human, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Virology Program, UPMC Hillman Cancer Center.
- Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, and.
- Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Förderung
- NIDCR NIH HHS
Zitieren
APA
Warner, B. E., & Shair, K. H. (2025). High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci189207
Vancouver
Warner BE, Shair KH. High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma. Journal of Clinical Investigation. 2025. doi:10.1172/jci189207
BibTeX
@article{Warner2025,
author = {Warner, Benjamin E and Shair, Kathy Hy},
title = {High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci189207}
}
EUVIMED